Sandrin C. Bergheanu

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

Gideon M. Hirschfield, Christopher L. Bowlus, Marlyn J. Mayo et al. · New England Journal of Medicine · 2024 · 192 citations

Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction

Bas L. van der Hoeven, Su‐San Liem, Jouke Dijkstra et al. · JACC: Cardiovascular Interventions · 2008 · 84 citations

Percutaneous Coronary Intervention, Bare-metal Stent Implantation, Stent Malapposition +10

Usefulness of Peak Troponin-T to Predict Infarct Size and Long-Term Outcome in Patients With First Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention

Ayman K.M. Hassan, Sandrin C. Bergheanu, Hosam Hasan‐Ali et al. · The American Journal of Cardiology · 2009 · 78 citations

Percutaneous Coronary Intervention, Predict Infarct Size, Cardiovascular Disease +10

Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins

Sandrin C. Bergheanu, Theo Reijmers, Aeilko H. Zwinderman et al. · Current Medical Research and Opinion · 2008 · 73 citations

Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol

Sandrin C. Bergheanu, Arie van Tol, Geesje M. Dallinga‐Thie et al. · Current Medical Research and Opinion · 2007 · 41 citations